Skip to content
← Companies
Perrigo

Perrigo

pharma
Dublin, · PRGO · Public
Perrigo is navigating significant leadership transitions following CEO Patrick Lockwood-Taylor's resignation over personal conduct violations, with interim CEO Albert Manzone now steering the company. The company faces financial headwinds with an unsustainable dividend yield of 10.9%, distressed balance sheet, and recent asset divestitures including its Dermacosmetics business, though Q1 earnings beat estimates and specialty care brands show momentum.

Perrigo Company plc specializes in delivering readily available, non-prescription health and well-being products. Its core mission is to elevate personal health by empowering individuals to proactively manage or address common conditions without professional intervention. The company's operations are strategically divided into two main segments: Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas division is primarily focused on the creation, production, promotion, and sale of private label self-care products. These offerings span a diverse range of categories, including remedies for upper respiratory issues, pain relief and sleep aids, digestive health, nutritional items (such as vitamins, minerals, and supplements), healthy lifestyle products, skincare, personal hygiene, and oral self-care. This segment serves markets across the United States, Mexico, Canada, and South America. Its product portfolio includes well-known brands like Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees. Conversely, the Consumer Self-Care International segment is dedicated to developing, manufacturing, marketing, and distributing consumer health brands. These products reach consumers through a comprehensive distribution network that includes pharmacies, wholesalers, drugstores, grocery retailers, and para-pharmacies. This segment operates in approximately 23 countries, with a primary focus on the European market. Beyond its own product lines, Perrigo also offers specialized contract manufacturing services. Established in 1887, Perrigo Company plc maintains its corporate headquarters in Dublin, Ireland.

Employees
8,379
Mfg Plants
6
All Facilities
12
Activity
6/10
Type
Public

Plant Locations (12 mapped)

PRGO Stock Price

Manufacturing Plants (6)

Perrigo Allegan Manufacturing & Operations Campus
Allegan, MI
Primary US manufacturing campus founded 1887; ~1.8 million sq ft of manufacturing, distribution, R&D, and office space; produces OTC pharmaceuticals (analgesics, cough/cold, GI, feminine hygiene), nutritional products, and active pharmaceutical ingredients; Perrigo's largest single site
Perrigo Pharmaceutical — Minneapolis/New Hope Manufacturing (ex-Paddock Labs)
Minneapolis, MN
Generic pharmaceutical manufacturing facility; acquired with Paddock Laboratories for $540M in 2011; manufactures generic Rx and OTC liquids, tablets, powders, gels, and suppositories; FDA ANDA approvals on record at this address; approximately 450 employees at acquisition
Perrigo New York — Bathgate Avenue Manufacturing
Bronx, NY
OTC pharmaceutical manufacturing plant at 1625/1700/1701 Bathgate Ave; ~200+ Teamsters Local 210 union employees; manufactures arthritis topical gel, hemorrhoid suppositories, and other private-label OTC medicines; classified NAICS 325412
Perrigo Nutritionals — Covington Ohio Infant Formula Plant
Covington, OH
Highly automated infant formula manufacturing facility; acquired from PBM Holdings in 2010 (formerly Kerry Inc.); one of Perrigo's two primary formula production sites; filed for $8M expansion for infant formula equipment tower; largest employer in Covington area
Perrigo Nutritionals — Georgia Vermont Infant Formula Plant
Georgia, VT
Infant formula manufacturing facility in Georgia Industrial Park, Franklin County; acquired from PBM Holdings in 2010; ~420 employees at peak; Perrigo announced closure in March 2025, phasing out production through mid-2026 due to facility age and regulatory requirements
Perrigo Wisconsin — Eau Claire Infant Formula Plant (Gateway)
Eau Claire, WI
Powdered infant formula manufacturing facility acquired from Nestlé (Good Start brand) in November 2022 for $110M as part of $170M investment including $60M plant expansion; in Gateway Industrial Park; received FDA 'No Action Indicated' after 2024 inspection

Other Facilities (6)

Perrigo Holland Distribution Center
Holland, MI · distribution
357,000 sq ft consolidated distribution center completed 2021; main US finished-goods distribution hub for OTC product lines; consolidates five previous warehouse locations
Perrigo Holland Lincoln Road Warehouse
Holland, MI · distribution
Additional Perrigo warehouse/CRM warehouse facility in Holland; part of the broader West Michigan distribution network
Perrigo Pharma — Duncan South Carolina Distribution/Packaging
Duncan, SC · distribution
300,000 sq ft leased facility; Perrigo Pharma International DAC; pharmaceutical packaging and distribution operations; relocated and expanded from Greenville SC Technology and Aviation Center
Perrigo North American Headquarters
Grand Rapids, MI · hq
North American corporate HQ opened 2022 in MSU Grand Rapids Innovation Park (Medical Mile); 63,550 sq ft on top 3 floors of 125,000 sq ft building; houses Consumer Self-Care Americas leadership
Perrigo Nutritionals — Charlottesville Virginia Office
Charlottesville, VA · hq
Nutritionals division office; inherited from PBM Holdings acquisition in 2010; houses Perrigo Nutritionals administrative and commercial functions; not a manufacturing site
Perrigo R&D — Piscataway New Jersey
Piscataway, NJ · r&d
Pharmaceutical research and development laboratory; approximately 45 employees; supports OTC and generic Rx drug development programs